Psychedelic Medicine

Reforming Outdated Barriers to Research on Mental Health and Addiction Treatment

Written by Bridget McQuillan and Jazz Glastra "As a researcher, I always hesitate to go into doing research with Schedule I drugs,” said Dr. Nora Volkow, Director of the National Institute on Drug Abuse, or NIDA, in 2021 (Jager, 2021). NIDA, part of the federal government’s National Institutes of Health, funds and conducts billions of dollars’ wort...

Event Announcement: Welcome to the Future of Rapid-Acting Mental Health Treatments

On May 18, join BrainFutures and the Frontier Psychiatrists at Rapid-Acting Mental Health Treatment (RAMHT 2025) in Los Angeles, CA, as we explore the latest developments in rapid-acting treatments for mental health. The event takes place at the Skyline Loft on the second night of the American Psychiatric Association annual conference less than a mile from the co...

Live Provider Roundtable: Integrating Psychedelic Therapies into Healthcare

Save the Date! BrainFutures is excited to invite you to a Virtual Provider Roundtable on April 1st at 12 PM EST / 9 AM PST. Click here to register now to join the conversation!  This session is a follow-up to BrainFutures and the Collaborative of the Economics for Psychedelics’ new whitepaper, Scaling Psychedelics in the Health System. This roundtable w...

New Healthcare Provider Survey Reveals Both Opportunities and Barriers in Planned Adoption of Psychedelic Therapy

New Healthcare Provider Survey Reveals Both Opportunities and Barriers in Planned Adoption of Psychedelic Therapy  Health providers plan rapid adoption of psychedelic therapy, but anticipate delays in insurance coverage  LUTHERVILLE, MD AND BERKELEY, CA – March 10, 2025 – A survey of mental health providers from 15 states revealed both opportunities a...

New NORC/BrainFutures Study Finds Psychedelics in Healthcare Practitioner Training is Growing

New NORC/BrainFutures Study Finds Psychedelics in Healthcare Practitioner Training is Growing Research gauged level of clinician workforce preparedness and education in anticipation of possible FDA approval for psychedelic therapies CHICAGO and LUTHERVILLE, MD – December 11, 2024 – In a comprehensive survey of academic leaders from counseling, social work...

BrainFutures' Response to the Psychedelics Advancing Therapies (PATH) Caucus's Request for Information on Psychedelic Medicine

The bipartisan PATH Caucus is seeking feedback on how to create policies and programs for emerging therapies involving psychedelic or entactogenic substances in medically supervised, supportive settings. They aim to better inform Congressional members by educating them about innovative, evidence-based therapies involving psychedelics, as well as the consideration...

Rapid-Acting Mental Health Treatment Summit Aims to Lead the Conversation on What’s Next in Mental Health

November 1, 2023 – BrainFutures, a national nonprofit dedicated to advancing practical applications of new scientific understanding of the brain, will co-host the upcoming Rapid-Acting Mental Health Treatment 2024 (“RAMHT 2024”) an in-person event on January 7th, 2024 in San Francisco. RAMHT 2024 will be jointly led by Dual-boarded Child and Adult Psych...

A Firefighter’s Story: Finding Self-Compassion through MDMA-Assisted Therapy

First responders stand as pillars of strength and courage, but it is easy to forget that even the bravest among us can carry hidden burdens. John, a seasoned fireman, discovered this truth when he stumbled upon a documentary about MDMA-assisted therapy (MDMA-AT) for PTSD. What started as a curiosity led him on a path toward self-discovery. John’s journey...

BrainFutures Releases Psychedelic-Assisted Therapy Coding Guide to Streamline Future Insurance Reimbursement

BrainFutures Releases Psychedelic-Assisted Therapy Coding Guide to Streamline Future Insurance Reimbursement September 25, 2023 – In an effort to make psychedelic-assisted therapy affordable and accessible once it is approved by the U.S. Food and Drug Administration, BrainFutures announces the release of their latest issue brief, A Guide to CPT and HCPCS C...

Reason for Hope, The Veteran Mental Health Leadership Coalition, and BrainFutures Unite to Provide Comments on FDA Guidance for Psychedelic Drugs and Clinical Investigation

Reason for Hope, The Veteran Mental Health Leadership Coalition, and BrainFutures Unite to Provide Comments on FDA Guidance for Psychedelic Drugs and Clinical Investigation August 31, 2023 – A coalition of psychedelic-assisted therapy and mental health advocacy organizations has united to provide collective insight on the psychedelic drug and clinical inve...